Sign in
4

Changes in Ownership

ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-19-026842

Options or other derivatives

  • President and CEO acquired 281,798 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
DAVIS STEPHEN President and CEO 2019-04-29 Grant or award · Stock Options (Right to Buy) +219,298 219,298 D
DAVIS STEPHEN President and CEO 2019-04-29 Grant or award · Restricted Stock Units +62,500 62,500 D
Loading xslF345X03/doc4.xml…